Brain natriuretic peptide kinetics during dynamic exercise in patients with chronic heart failure.

[1]  U. Janssens,et al.  brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. , 2002, Journal of the American College of Cardiology.

[2]  P. Krishnaswamy,et al.  Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: implications for outpatient monitoring with B-type natriuretic peptide. , 2002, American heart journal.

[3]  H. Kawai,et al.  Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment. , 2001, American heart journal.

[4]  U. Janssens,et al.  Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide. , 2001, Clinical chemistry.

[5]  L. Lenert,et al.  Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. , 2001, Journal of the American College of Cardiology.

[6]  L. Lenert,et al.  A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. , 2001, Journal of the American College of Cardiology.

[7]  I. Hisatome,et al.  Augmented response in plasma brain natriuretic peptide to dynamic exercise in patients with left ventricular dysfunction and congestive heart failure , 2000, Journal of internal medicine.

[8]  D. Barnett,et al.  Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction. , 2000, European heart journal.

[9]  C. Frampton,et al.  Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations , 2000, The Lancet.

[10]  M. Kinoshita,et al.  Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. , 1999, European heart journal.

[11]  J. Mair,et al.  Relationship between natriuretic peptides and hemodynamics in patients with heart failure at rest and after ergometric exercise. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[12]  M. Jensen-Urstad,et al.  Comparison of different echocardiographic methods with radionuclide imaging for measuring left ventricular ejection fraction during acute myocardial infarction treated by thrombolytic therapy. , 1998, The American journal of cardiology.

[13]  D. Fukai,et al.  Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure. , 1997, American heart journal.

[14]  K. Kangawa,et al.  EFFECT OF EXERCISE ON PLASMA ADRENOMEDULLIN AND NATRIURETIC PEPTIDE LEVELS IN MYOCARDIAL INFARCTION , 1997, Clinical and experimental pharmacology & physiology.

[15]  D. Nicholls,et al.  Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects , 1997, European journal of clinical investigation.

[16]  K. Nakao,et al.  Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. , 1995, The Journal of clinical investigation.

[17]  K. Inouye,et al.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. , 1991, The Journal of clinical investigation.

[18]  J R Wilson,et al.  Value of Peak Exercise Oxygen Consumption for Optimal Timing of Cardiac Transplantation in Ambulatory Patients With Heart Failure , 1991, Circulation.

[19]  M. Mcgoon,et al.  Failure of atrial natriuretic factor to increase with volume expansion in acute and chronic congestive heart failure in the dog. , 1989, Circulation.

[20]  A. Kenny,et al.  Role of endopeptidase‐24.11 in the inactivation of atrial natriuretic peptide , 1988, FEBS letters.

[21]  E. Suzuki,et al.  Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. , 1995, American heart journal.